Johnson & Johnson ($JNJ) reported a favorable verdict from a federal jury regarding defective design of a blood thinner. This is the third straight win for the company in Xarelto case. Johnson & Johnson was sued by more than 20,000 users of the drug.
Retractable Technologies ($RVP) stock slumped as the Texas District Court judge determined that Retractable is eligible for no compensation in its antitrust lawsuit against Becton, Dickinson & Company. The judge also dismissed the case. Retractable says it is mulling its options, including a motion for a new trial or amend the judgement and appeal the decision.